Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22.05
38.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NZD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Fisher & Paykel Healthcare Corporation Ltd
Fisher & Paykel Healthcare Corporation Ltd
Research & Development
Fisher & Paykel Healthcare Corporation Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
|
Research & Development
-NZ$198.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Truscreen Group Ltd
NZX:TRU
|
Research & Development
-NZ$877.3k
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Fisher & Paykel Healthcare Corporation Ltd
Glance View
Fisher & Paykel Healthcare Corporation Ltd., a leading provider of innovative medical devices and respiratory products, has carved a prominent niche in the global healthcare market. Founded in New Zealand in 1934, the company has evolved from a humble appliance manufacturer into a key player in respiratory care and sleep medicine. With a mission centered on improving patient outcomes, Fisher & Paykel leverages its strong research and development capabilities to create state-of-the-art products, such as its award-winning humidifiers and nasal mask systems, designed to support patients with respiratory issues and obstructive sleep apnea. The company boasts a diverse international presence, with a robust distribution network that allows it to serve healthcare professionals and patients in over 120 countries. For investors, Fisher & Paykel stands out not only for its continual focus on innovation but also for its stable financial performance. Throughout its history, the company has demonstrated resilience and adaptability, adeptly navigating market fluctuations and healthcare trends. With a strong balance sheet, a consistent track record of revenue growth, and a commitment to shareholder returns, Fisher & Paykel is well-positioned for future expansion, particularly as global healthcare demands rise. As the aging population and the increasing prevalence of chronic respiratory conditions drive market growth, investors may find Fisher & Paykel Healthcare a compelling opportunity, with its blend of innovative solutions and solid financial foundations paving the way for sustained success.
See Also
What is Fisher & Paykel Healthcare Corporation Ltd's Research & Development?
Research & Development
-198.2m
NZD
Based on the financial report for Mar 31, 2024, Fisher & Paykel Healthcare Corporation Ltd's Research & Development amounts to -198.2m NZD.
What is Fisher & Paykel Healthcare Corporation Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-15%
Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for Fisher & Paykel Healthcare Corporation Ltd have been -13% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
